Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

US Election 2016

Set Alert for US Election 2016

Medical Innovation Bills On Fast Track In Congress, But Some Barriers Remain

With an all-Republican House, Senate and administration lined up to lead the government following the 2016 elections, the path is clear for passage of a set of FDA reforms to ease device approvals embedded in a combined House 'Cures' and Senate medical innovation package. It could even happen over the upcoming lame-duck session, before the new administration and Congress take over. But controversy around price-gouging by drug firms still could stymie quick Cures bill passage, an industry attorney predicts. Meanwhile, medtech industry groups plan to seize on the Trump victory as a means to achieve permanent device tax repeal.

US Election 2016 Policy & Regulation Legislation

Latest From US Election 2016 &Medical Device

CMS Nominee Seema Verma Urges Caution On Competitive Bidding Program

Seema Verma, President Trump’s pick to run the US Medicare agency, told the Senate Finance Committee that rural areas should not have to comply with CMS’ medical supplies competitive-bidding program if it is not a good fit. Verma was also questioned on changes she might make to the Affordable Care Act and the Medicare program, but did not offer many specifics.

Policy Reimbursement

US FDA Could Be Mostly Spared From Trump's Regulation-Slashing Order

Even though the executive order that requires regulatory offsets may only have limited application to the agency, industry experts warn that it still could prove to be unwieldly to implement.

Regulation FDA

Price Wins Confirmation As US Health Secretary; Verma On Deck For CMS Hearing

Senators voted 52 to 47 to confirm Rep. Tom Price, R-Ga., as Health and Human Services secretary, where he will be a key leader implementing reversals to the Affordable Care Act. Meanwhile, Trump’s pick to lead the Medicare agency, Seema Verma, faces a confirmation hearing in the Senate Feb. 16.

Policy Legislation

As ACA 'Repeal-And-Replace' Plans Form, Some Senators Silent On Device Tax Repeal

As Obamacare repeal-and-replace plans begin to take shape in the Senate, not all of the legislative proposals include provisions to repeal the medical device tax, and fewer senators in the 2017-2018 Congress have signed on to support repeal of the tax than did in the early days of the prior Congress.

Policy Legislation

US Regulatory Reads, January: Top 10 Includes Trump, But Also FDA Fundamentals

Actions coming out of the Trump administration are important to Medtech Insight readers, but so are detailed coverage of FDA policies not yet specifically impacted by the political change, as our top-10 US regulatory and policy stories in January shows.

Regulation Policy

AdvaMed Anti-Device Tax Campaign Takes Aim At Reconciliation Bill

The medical device lobby group is targeting lawmakers on the Hill and in key states in a new campaign intended to ensure permanent repeal of the 2.3% device tax is part of a future congressional budget reconciliation bill.

Legislation US Election 2016
See All